Both in Pharmaceuticals
Heron Therapeutics vs Clene
Over the past year HRTX returned −76.1% and CLNN returned −69.4%; their daily moves had a correlation of 0.02.
HRTX −76.1% CLNN −69.4%Growth of $1, one year, split-adjusted
| Metric | HRTX | CLNN |
|---|---|---|
| Price | $0.2777 | $3.83 |
| Market cap | $52.7M | $54.4M |
| Today | −5.67% | −1.79% |
| 1 month | −22.0% | −4.7% |
| 6 months | −78.1% | −37.6% |
| Year to date | −78.6% | −34.8% |
| 1 year | −76.3% | −58.1% |
| Revenue growth (YoY) | +1.3% | +233.3% |
| Gross margin | 69.3% | 60.0% |
| Net margin | −14.6% | −14915.6% |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | 276.3× |
| Net cash | -$100.0M | -$9.1M |
| Dividend yield | — | — |
| Volatility (60d) | 115.7% | 81.7% |
| Short % of float | 25.7% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).